Qu
Quotient Ther
Cambridge MAFounded 202230 employees
Private CapbiotechPrivateGenetic Medicine
Platform: SC Genomics
Market Cap
N/A
All Drugs
4
Clinical Trials
7
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| QUO-6518 | QUO-6518 | Preclinical | 2 | CD38 | ETGIST | ||
| QUO-7972 | QUO-7972 | NDA/BLA | 1 | BCMA | RettAtopic Derm | ||
| QUO-3159 | QUO-3159 | Approved | 3 | PRMT5 | HST2D | ||
| QUO-8015 | QUO-8015 | Phase 1 | 1 | TROP-2 | GISTCRC |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (8)